BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1371176)

  • 1. Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography.
    Hou DY; Maruyama Y
    J Surg Oncol; 1992 Feb; 49(2):93-7. PubMed ID: 1371176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.
    Hou DY; Hamburger AW; Beach JL; Maruyama Y
    Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome aberrations of human small cell lung cancer induced by a new 111In-bleomycin complex.
    Hou DY; Maruyama Y; Drago JR
    J Surg Oncol; 1992 Dec; 51(4):236-42. PubMed ID: 1279317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex.
    Hou DY; Maruyama Y
    J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex.
    Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y
    J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
    J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines.
    Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
    Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Int J Nucl Med Biol; 1984; 11(2):129-39. PubMed ID: 6207129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer.
    Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
    J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.
    Hosono M; Hosono MN; Haberberger T; Zamora PO; Guhlke S; Bender H; Knapp FF; Biersack HJ
    Jpn J Cancer Res; 1996 Sep; 87(9):995-1000. PubMed ID: 8878464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models.
    Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV
    Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
    Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
    Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE
    J Surg Oncol; 1984 Mar; 25(3):168-75. PubMed ID: 6199622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells.
    Fujimoto J
    Cancer Res; 1974 Nov; 34(11):2969-74. PubMed ID: 4138662
    [No Abstract]   [Full Text] [Related]  

  • 18. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
    Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of olfactory neuroblastoma by In-111 bleomycin complex.
    Jekunen AP; Kairemo KJ; Ramsay HA; Kajanti MJ
    Clin Nucl Med; 1996 Feb; 21(2):129-31. PubMed ID: 8697683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of indium-111 BLEDTA in man.
    Sartoris DJ; Goodwin DA; Meares CF; DeRiemer LH; Fajardo LF
    Invest Radiol; 1984; 19(3):221-7. PubMed ID: 6206021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.